|
English
|
正體中文
|
简体中文
|
总笔数 :2853327
|
|
造访人次 :
45005540
在线人数 :
1909
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"spira a i"的相关文件
显示项目 1-5 / 5 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-08-10T02:37:39Z |
Amivantamab in egfr exon 20 insertion- mutated non-small-cell lung cancer progressing on platinum chemotherapy: Initial results from the chrysalis phase i study
|
Park K.; Haura E.B.; Leighl N.B.; Mitchell P.; Shu C.A.; Girard N.; Viteri S.; Han J.-Y.; Kim S.-W.; Lee C.K.; Sabari J.K.; Spira A.I.; Yang T.-Y.; Kim D.-W.; Lee K.H.; Sanborn R.E.; Trigo J.; Goto K.; Lee J.-S.; CHIH-HSIN YANG; Govindan R.; Bauml J.M.; Garrido P.; Krebs M.G.; Reckamp K.L.; Xie J.; Curtin J.C.; Haddish-Berhane N.; Roshak A.; Millington D.; Lorenzini P.; Thayu M.; Knoblauch R.E.; Cho B.C. |
| 臺大學術典藏 |
2022-08-10T02:37:38Z |
Brigatinib Versus Crizotinib in ALK Inhibitor�VNaive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
|
Camidge D.R.; Kim H.R.; Ahn M.-J.; CHIH-HSIN YANG; Han J.-Y.; Hochmair M.J.; Lee K.H.; Delmonte A.; Garcia Campelo M.R.; Kim D.-W.; Griesinger F.; Felip E.; Califano R.; Spira A.I.; Gettinger S.N.; Tiseo M.; Lin H.M.; Liu Y.; Vranceanu F.; Niu H.; Zhang P.; Popat S. |
| 國立成功大學 |
2021 |
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
|
Even, C.;Wang, H.-M.;Li, S.-H.;Ngan, R.K.-C.;Dechaphunkul, A.;Zhang, L.;Yen, C.-J.;Chan, P.C.;Chakrabandhu, S.;Ma, B.B.Y.;Tanasanvimon, S.;Lee, V.H.F.;Lou, P.-J.;Li, Z.;Spira, A.I.;Sukari, A.;Guigay, J.;McCune, S.;Gonzalez-Maffe, J.;Szpakowski, Szpakowski S.;Yao, Yao Y.;Liang, H.;Mataraza, J.;Sechaud, R.;Manenti, L.;Lim, D.W.-T. |
| 臺大學術典藏 |
2020-05-25T07:35:26Z |
Cabozantinib in patients with advanced prostate cancer: Results of a phase II randomized discontinuation trial
|
Smith D.C; Smith M.R; Sweeney C; Elfiky A.A; Logothetis C; Corn P.G; Vogelzang N.J; Small E.J; Harzstark A.L; Gordon M.S; Vaishampayan U.N; Haas N.B; Spira A.I; Lara Jr. P.N; Chia-Chi Lin; Srinivas S; Sella A; Sch?ffski P; Scheffold C; Weitzman A.L; Hussain M. |
| 臺大學術典藏 |
2020-05-25T07:35:09Z |
Safety and efficacy of the PD-1 inhibitor ABBV-181 in patients with advanced solid tumors: Preliminary phase I results from study M15-891
|
Powderly J; Cassier P.A; Cervantes A; Gao B; Gazzah A; Italiano A; Chia-Chi Lin; Luke J.J; Moreno V; Peltola K; Rasco D; Spira A.I; Tanner M.M.E; Tosi D; Afar D; Englert S; Parikh A; Reddy A; Vosganian G; Tolcher A.W. |
显示项目 1-5 / 5 (共1页)
1
每页显示[10|25|50]项目
|
